Mesalazine - Wikipedia
Tofacitinib in ulcerative colitis | Immunotherapy
Frontiers | Glucocorticoid Therapy in Inflammatory Bowel Disease: Mechanisms and Clinical Practice | Immunology
Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis - Gastroenterology
![5-aminosalicylates [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/slide1.png?w=600&tok=62b6d2 "5-aminosalicylates [TUSOM | Pharmwiki]")
5-aminosalicylates [TUSOM | Pharmwiki]
Cureus | Efficacy and Safety of Vedolizumab in Management of Moderate to Severe Ulcerative Colitis: A Systematic Review
Pentasa Full Prescribing Information, Dosage & Side Effects | MIMS Thailand
Carcinogenesis in Ulcerative Colitis | IntechOpen
Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal?
Mesalazine and inflammatory bowel disease – From well-established therapies to progress beyond the state of the art - ScienceDirect
Frontiers | Vedolizumab: Potential Mechanisms of Action for Reducing Pathological Inflammation in Inflammatory Bowel Diseases | Cell and Developmental Biology
Some putative molecular mechanisms that underlie the antineoplastic... | Download Scientific Diagram
Tofacitinib inhibits inflammatory cytokines from ulcerative colitis and healthy mucosal explants and is associated with pSTAT1/3 reduction in T-cells | American Journal of Physiology-Gastrointestinal and Liver Physiology
PHARMACOLOGY OF COMBINED MESALZINE AND RIFAXIMIN THERAPY TO INFLAMMATORY BOWEL DISEASE | PharmaTutor
![PDF] Mechanisms of Action of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Mesalazine in the Chemoprevention of Colorectal Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ac52ce7ed75f2e8b70b1e3e603f5bf5cc19d010f/5-Figure2-1.png "PDF] Mechanisms of Action of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Mesalazine in the Chemoprevention of Colorectal Cancer | Semantic Scholar")
PDF] Mechanisms of Action of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Mesalazine in the Chemoprevention of Colorectal Cancer | Semantic Scholar
My Gastro Room: Mesalazine delivary system
Ulcerative colitis
Drug Insight: aminosalicylates for the treatment of IBD | Nature Reviews Gastroenterology & Hepatology
Some putative molecular mechanisms that underlie the antineoplastic... | Download Scientific Diagram
New therapeutic avenues in ulcerative colitis: thinking out of the box | Gut
pH‑dependent vs. constant release of mesalazine in the treatment of ulcerative colitis: Do drug delivery concepts determine therapeutic efficacy? (Review)
Induction of Colonic Regulatory T Cells by Mesalamine by Activating the Aryl Hydrocarbon Receptor - ScienceDirect
Review article: mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease - Allgayer - 2003 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
IJMS | Free Full-Text | Mechanisms of Action of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Mesalazine in the Chemoprevention of Colorectal Cancer
Targeting NF-κB pathway for treating ulcerative colitis: comprehensive regulatory characteristics of Chinese medicines | Chinese Medicine | Full Text
Ulcerative Colitis: Today, Tomorrow, and the Future - European Medical Journal
Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal?
Ulcerative colitis - The Lancet
